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MALARIA WITHOUT QUININE

ROBERT A. LEHMER

SENIOR THESIS PRESENTED TO THE COLLEGE
OF MEDICINE#
UNIVERSITY OF NEBRASKA# OMAHA# 1943

-l.
Any progressive mon of Nedicine, whether
he be expertly schooled ond exquisitely train
ed or for ihe f£rsi iime seated in o freshnon
Anotony leoture, is still o "Student of Ned£Suoh men ore cognizant of the foot thot
this second World War is now and will continue
to throw mony burdens on the hypotheiiool
shoulders of the Medical Profession; both in
the guise of Supply and Demand of the present
and in that of oompliooting changes necessary
in the practice of aedicine when our boys cone
bock, accompanied by diseases (new or forgot
ten) ond in the need of completely rearranged
medical services (geogrophioally).
In the lost wor, molaria too� first ploce
omong the diseases responsible for casualties
and our clever enemies took first odvontoge
of this bit of knowledge, quickly ooting to
toke the Netherland Eost Indies. When this
conquest wos ooorediied, we found thot the
source of procticolly the entire world supply
of quinine wos lost to the United Notions.

g_.
With Japan holding fast to the supply
house of the only successful drug intimately
known to the therapy of malaria there were
only two avenues open for solution:

recon-

quest of the said losses or substitution of
a new and equally effective method of therapy which did not depend on any drug not
easily obtained from raw materials readily
accessible within our own possessive boundaries.
It is with this modern problem of Supply
and Demand that we shall attempt to deal by
presenting a survey of the literature to date,
giving both sides of the vario~s appraisals~
and trimming repetitious articles into one
sequential story.
First in line,

however, to a working

knowledge of any subject is a short history
of the principal factor, which in this case

is the disease molaria--so to those readers
who would not care for the repetition of a
spicey, different, and more descriptively,
a "tabie-talkn type of history, we say that

1,.

the oold, bare facts begin with the article
entitled, nMosquitoes".
HISTORY (1)
In current usage during the past century
the word malaria has come to designate any
member of a group of chronic infections produced by several species of protozoan parasites belonging to the family of plasmodidae.
The human infections are attributable to
three or more species of these parasites,
which for precision should be distinguished
by the name of the oausitive parasite as
faloiparum malaria, vivax malaria, and quartan malaria.
The origin of the term malaria is from
the Italian, umol" meaning bad, and "aria"
meaning air, as well as the term miasma
which designated a noxious exhalation in old
terminology.

These terms were used to desig-

nate the supposed exciting agent of these as
well as other diseases.
In just this sense, malaria was introduced into English literature by Mao Cullooh

!±.
(1829) who stated:

"It has long been famil-

iar to physicians that there was produced by

wet lands, or by marshes and swamps, a poisonous and acriform substance, the cause,
not only of ordinary fevers, but of intermittent
ones and to this unknown agent of disease the
term 'marsh miasma' has been appl£ed ••• Th£s
is the unseen, and still unknown poison to

which Italy applies the term that I have borrowed, 'malaria'"· One of the last expressions on the old viewpoint was afforded by
the following quotation from Sternberg (1884):
"The various types of intermittent and remittent fever wh£oh are cured by quinine are by
common consent recognized as due to malaria
poisoning, and ••• we must insist that the prevalence of per£odic fever be taken as the
test of the presence of malaria."
It is unfortunate for students of modern
medicine that they know little of the old
terminology and are thus slightly, £fat all,
conversant w£th the old writers.

For just

th£s purpose with regards myself and other

•

ireaders# let us here present some synonymi:
Vivax malaria: tertian fever1 benign tertian
fever, simple intermittent fever1 paroxysmal fever# tertian ague1 chills and
fever1 fever and ague.
Quartan malaria: quartan fever1 quartan ague1
simple intermittent fever1 paroxysmal
fever1 chills and fever.
Faloiparum malaria: tertian fever1 sestivoautumnal malaria1 malignant tertian
fever1 remittent fever 1 (including bilious# congestive and malignant types),
continued malaria fever, pernicious
fever1 congestive intermittent fever,
pernicious intermittent fever1 conges- tive fever1 congestive chills.
The diagnosis of remittent fever has been
applied to many cases of typhoid 1 while yellow
fever has masquaraded as bilious remittent
fever.

Regarding the history of immunity,

Kalm (1770) in speaking of "fever and ague"
in . southern New Jersey said1 "Strangers who
arrive here are commonly attacked by this

Q_.
sickness the first or second year of their
arrival. and it acts more violently upon them
than upon the natives.
die of , it.

so

that they sometimes

But if they escape the fi ·rst

time. they have the advantage of not being
visited again the next year or perhaps ever.
It is commonly said here that strangers get
the fever to accustom them to the climate."
Cumming (1810) stated. "All newcomers ar fe
subject to what is called a seasoning. after
which. though they may be annually attached
by this scourge of the climate. it rarely
confines them longer than a few days."
Regarding the progress in basic scientific knowledge. confirmation of Laveran's
discovery of the malarial parasite was affected by Sternberg in 1886. who demonstrated
the parasites in the blood of an active
clinical case.

This was several years before

effective staining techniques were introduced and in these early years microscopical
diagnosis was commonly done with fresh blood.
Long before it became possible to differentiate between yellow fever and faloiparum

1.
malaria a number of physioians in Amerioa
had oome to suspeot that mosquitoes were involved in the transmission of both diseases.
Although nearly forty years previously1 men
had advanoed suoh an idea1 it was King1 in
18831 who advanoed the following propositions:
1.

The malaria season oorresponds to the

mosquito abundanoe; 2.

Malaria oountry is

suitable to mosquito breeding; 3.

Similar

conditions afford protection against malaria
and mosquitoe_s; 4.

Exposure to night air

means exposure to mosquitoes; 5.

Soldiers1

tramps and fishermen are partioularly susceptible to malaria and are especially exposed to mosquitoes at night; 6. Turning up
the soil or making excavations in previously
healthy distriots is often fo l lowed by malaria;

7.

Coincidence of malaria and mos-

quitoes1 increase of both in l ate summer and
autumn.
Following the incrimination of mosquitoes in the transmission of yellow fever and
malaria1 studies emphasize the fact that

§...

effective anti-anopheline work requires an
extensive knowledge of the bionomios of local
vectors and that controlled measures must be
adapted to the character of the local problem
arising from these peculiarities.
Progress in treatment and prevention may
be traced from the tremendous importance of
the disclosure to European medicine that the
bark of a Peruvian tree could cure intermittent fever. It is alleged that as early as
1630, Don Juan Lopez had been cured of an
I

intermittent fever by the use of this bark.
The extent to which the bark came to general
use as a febrifuge in the Americas during
the next century and a half was obscure.

The

buccaneer surgeon, Lionel Wafer, 1699, appears to have become familiar with the Peruvian or Jesuit's bark in his cruise down the
west coast of South America in 1680-81, as he
speaks of observing it brought from the jungles on mule back for export in Africa and
Peru.

In the account of his adventures, we

read, "We brought away with us several bundles

iof this bark1 and I found it to be the right
sort, by the frequent use I made of it in
Virg£n£a and elsewhere."
As early as 17761 the Continental Congress ordered the medical comm£ttee to forward
300 lbs. of Peruvian bark to the Southern
Department for the use of the troops. Jackson, 1791, a British army surgeon attached
to one of the regiments of Lord Cornwallis

1

army, made extensive use of Peruvian bark
in treating the abundant intermittent fevers
from which the British army suffered £nits
southern campaign. At any rate, £ts use in
the United States appears to have become wide
spread subsequent to the Revolution.
Quinine was prepared commercially in
Philadelphia three years after its isolation
in 1820.

The earliest report of £ts employ-

ment in the United States has come to our attention through Henry Perrine in 1826, who
employed from 6 to 12 grains every two to
three hours at any period of the fever, continued until its symptoms in pulse and skin

lQ..
were subdued, repeating if the return of
fever was suggested.
Quinine soon became an ingredient of
proprietary fever remedies, one of the
earliest of which, Dr. Sappington's uantifever pills", was extensively sold throughout the Mississippi valley and the southwest
during the 30 1 s and 40's.

Dr. Sapp£ngton's

advice to use quinine as a prophylactic did
not attract much attention until the decade
immediately before the Civil War.

Merritt,

(1861), surgeon to a mining company in Panama in 1850, obliged all employees to take a
daily dose of 5 grains before breakfast.
Soon the crews of the vessels operated by the
Panama Railway Company were required to take
quinine while in certain malarial ports.

It

was reported successful as a prophylaxis among
the negro slaves engaged in the construction
of the Charleston and Savannah Railway and was
extensively, though not systematically, employed for this purpose during the Civil War.
Various study areas were located in the

LJ...
early 1900's to determine the effects and
dosages of quinine on the various populations in their respective areas.

Work began

to be done on the tro,nsformation of swamps
to rice fields etc. in the late 19th century
and thus attacks began to be made upon the
habitats of the newly found etiological
agents.

Just when screening of doors and

windows was introduced is uncertain although
some screen wire was manufactured as early as
1865# and the amount now manufactured for
domestic consumption and export is enormous1
in 1927 exceeding five hundred millions
square feet. Malaria will probably continue
to be endemic in many regions of the world
where any attempt to control this disease
based upon the application of available measures is beyond local resources.

The hope

of cheaper methods depends upon the requirement of new viewpoints to the problem# the
attainment of which necessitates an extension
of our knowledge.

Probably no better guide

to the means and opportunities for research

u_.
in the field of malaria can be secured than

through an inventory of existing knowledge
of all the aspects of malaria fever known to
man.
Although quinine and its use in the
treatment of malaria is to be a dropped subject in this article it would be well to remember a statement made by Mumford (2) and
to repeat his recommendations for the dosage
of the drug.

"Owing to a low toxicity, and

the fact that careful medical supervision is
not required, quinine is still the most valuable drug for malarial prophylaxis and the
treatment of acute malaria." But it is
claimed that quinine is much too valuable to
be used as a prophylactic (to be saved for
acute therapy) where there is doubt of the
danger of becoming infected.
"Rx: Quinine; 1. Ordinary adult coses,

0.5 to 0.65 grm daily. 2~ Acute
malaria, 0.65 grm. orally two or three times
a dose of

daily for three or four days or until acute
symptoms disappear.

Then a dose of 0.65 grm.

u.
is given every night for eight weeks.

( Good-

~an Gilman 1941)».
Perhaps the location of our present theater of war will change# but unless it does so
quite quickly and quite unexpectedly, we will
do well to remember that this historical disease# malaria# is "believed to occur in all
the islands between the equator and 20 degrees
S.# from New Guinea eastwards to 170 degrees
E •• n (3).

MOSQUITOES
Since King convicted the mosquitoes as
the vectors and their presence is very nearly

a necessity to the incidence of any type of
malaria# let us make a very brief outline
survey of the mosquitoe situation:

For our

present purposes we can begin by stating that
true mosquitoes possess the following characteristics:
a. The arrangement of their wing-veins is

characteristic.
b. They have a long proboscis which is adapted
for sucking up fluids.

In the female sex

JJL.
of most, but not all, species the proboscis
is also adapted for piercing the skin.
c. The veins on their wings are clothed with

true scales.
Although in all true mosquitoes the proboscis is long (usually about the length of
the abdomen) and is adapted for sucking up
fluids, by no means are all species bloodsuckers, and no male mosquitoes have this

habit.
Many species feed on plant juices, and
the members of one small genus have the very
curious habit of living in association with
ants which supply them with food.
In most countries one or two species are
much more actively concerned with the spread
of malaria than others.

Major Christophers

has compiled the following list of species
which he considers, (on account of their known
habits, carrying powers, relative prevalence
and widespread distribution), may be regarded
as the chief malaria-carrying species in the

particular countries, but only those which

1..5...
hove been most frequently found to be responsible for the spread of the disease:
IN EUROPE AND NORTH AMERICA: A. moculi,pennis
and its allied species A. quodrimaculotus
and A. occidentolis.
IN SOUTHERN EUROPE: A. superpiotus and A.
bi,furcatus.
IN UNITED STATES: A. quadrimaculatus and A.
crucians.
IN CENTRAL AND SOUTH TROPICAL AMERICA AND THE
WEST INDIES: A. albimanus and A. argyritarsis.
IN SOUTHERN SPAIN AND NORTH AFRICA: A. turkhud i,.
IN GREECE, ASIA MINOR, PALESTINE, ETC.: A.
super ictus.
IN THE MEDITERRANEAN: A. pseudopictus.
IN MESOPOTAMIA: A. stephensi.
IN INDIA: A. culicifaoies, A. listoni, A.
s .t e p hens i,, etc.
IN THE MALAY STAT ES: A. min imus, A. ma cul a tus,
A. 1udl owi.
IN THE MALAY ARCHIPELAGO AND NEW GUINEA: A.
leucosphyrus and A. tesselatus.

u_.
IN NORTH AUSTRALIA: A. annulipes.
THROUGHOUT AFRICA AND IN SOUTHERN ARABIA: A.
funestus and A. oostalis.
IN SOME FOREST REGIONS: A. plumbeus (Europe),
A. lutzii (Central Amerioa).
One man (4) suggests the oonviction of
children as well as mosquitoes because they
are responsible for the principal maintenance
of malarial infection in hyperendemio areas.
This, he contends, is explained by the fact
that young children develop an immunity very
s 1 owly.

Congenital malaria, although a disputed
fact by many, is presented as a proven foot
and there are several cases reported in support of suoh a contention.
There are several considerable differences
between child and adult malaria and their respective clinical pictures.
are:

The main of these

1. The frequent absence of fever; 2. Its

irregularity, if present; 3. The predominance
of digestive symptoms; 4. The common excitation
into activity of latent conditions; 5. The

relatively large doses of quinine necessary
to cure; 6. While a leukopenia is the rule,
many oases of malaria (aestivo-autumnal)
have a high leukocyte count with a high percentage of polys;

?. Attention is called to

a pyelitis that often exists in a malarial
patient possibly overshadowing the primary
condition, but clearing quickly under proper
therapy.
But now, on to a survey of the newer
drugs, which for the sake of some order, we
have divided into separate treatments of:
1. Atabrine, 2. Plasmoohin, 3. Sulfonamides,

4. Combinations of these, and 5. Miscellaneous.
ATABRINE (5)
Chemistry. Atabrine, 2-methoxy-6-chlor-9- (a-methyl-S-diethylaminobutyl) aminoacridine, is a substituted alkyl amino derivative of acridine. The side-chain in
, t his compound is the same as that in plasmochin. Substitutions can apparently be
made in this side-chain without seriously altering the antiplasmodial activity, but
. this does not seem to be true for plasmochin. The structural formula is as follows:

/
CHaO \._
C2Hs

~

I
H I
N · CH2 · CH2 · CH2 · C-NH
I

C2Hs

CHa

Atabrine
Atabrine is a yellow bitter powder. It is usually marketed as the dihydrochloride salt in yellow tablets, or as the powder which dissolves in water to the extent of three per cent to form a neutral fluorescent solution. The drug is not
official and is not included in N.N.R,

l..[.

In a reoent artiole to the lay we find
that this subjeot of ours hos beoome a matter
of publio interest and the reasons, simply
stated but oompletely inadequate for the oonolusions drown, warrant some quotation from
a historioal standpoint only.

nzt was a prewar mistake of the Germans
that their dye trust, I. G. Farbenindustrie,
underestimating the ingenuity of Amerioan
ohemists, let us in on a hint of Atobrine's
secret.

German ohemists had been working

on synthetio quinine for years; their Naz£
masters knew that no bid for world oonquest
could be made without a substitue for quinine, beoause malarial soldiers are just
too sick to fight •••
For Nazi warlords, concerned with transport, Atabrine had this enormous advantage:
one ton of it would cure 600,000 malarious
people, while the some amount of quinine
would cure only 30,000.

The Germans tried

it out experimentally in Rumania, Ital~ Spain,
Africa and the East Indies.

Back came a

u.
roaring yes of scientific approval.

With

the new drug one could live in health despite
swarms of deadly molario mosquitoes.

It was

a German monopoly1 a master weapon1 and now

Hitler's 'Wehrmaoht' was ready and rarin' to
go.
But at this point the German dye trust
made its blunder.

The Germans sold these-

cret of Atabrine to America!

They thought

they were driving a sharp bargain1 because
they deliberately left out vital pieces of
the chemical jigsaw puzzle of the synthesis
of Atabrine.

They reckoned without the in,

genuity of Dr. A. E. Sh~rndal of the Winthrop
Chemical Company.

Sherndal knew what the

missing ingredients were1 but could not obtain them in the United States.

(Ironically1

TNT and Atabr£ne1 one the destroyer1 one
the health giver, are made from the same
basic chemical.)

Sherndal therefore devised

a process of making Atabrine by using available American materials, and produced a
medicine identical with the German chemical.

gQ.

By 1939, Sherndal (who should have the highest military honors), succeeded in the mass
production of an American Atabrine.
More than a year before Pearl Harbor,
Dr. Parran not only forsaw the disastrous
consequences of our lack of quinine but suggested to the Winthrop Chemical Company the
urgency of stepping up Atabrine production.
Not waiting for government orders or financing, the Winthrop Company, with the help of
Merck and Company,

shot Atabrine production

up from 5,000,000 to 500,000,000 pills per
year.

Recently, the United States Army

placed a giant order for 270,000,000 of the
yellow pills--indispensable weapon in our
global sturgle for victory.

The American

high command knows that Atabrine will keep
our boys on their feet and fighting, wherever
they may be.

Millions of pills have been

flown to Brazil, to make possible successful
rubber production in the malaria-infested
jungle.

More millions have been flown to

Turkey--for that nation made it a primary

gj_.

consideration of its trade agreement that the
United States should protect Turkey from
malaria.
Characteristically, American mass production methods have lowered the price of
this lifesaving victory chemical from £ts
prohibitive German monopolistic high of $66
per 1,000 pills in 1933 to $4.50 per 1,000
today.

This means that when the disease is

tackled on a large scale on average case of
malaria can be cured for just a little over
six oents--the cost of an airmail letter! •••
But the final glowing promise of these
little yellow pills is not only for America,
it is for the 800,000,000 malaria sufferers

all over the world, with millions dying yearly.
In the postwar tomorrow we shall be faced
w£th a battered, maimed, starved, sick world.
You cannot rebuild a world with half of its
people drag-footed, shaking with malarial
chills, burning with malarial fever--now
curable at six cents per capita!

And we shall

meet at least part of our obligations toward

gg_.
reconstruction by producing and distributing
billions of yellow pills of AtGbrine that
will eventually conquer malaria.n
From the standpoint of strict# scientific
proof# we look first to the official report
of the National Research Council (6) which
states that Atabrine# now officially recognized under the nonproprietary name of Quinacrine# has assumed a role of unsurpassed importance as a strategic drug# and the American
Atabrine has been now proven to be genuine.
and comparable in every respect with that
produced in other countires.
Experimental work has been done# not
only on the dosage and effects of Atabrine
by the oral route but also by the intramuscular and intravenous routes as well# and
.some of these reoorts lead to conclusions
~

p r o whi 1 e o t he r s

#

t ho u g h g re a t 1 y i n t he

minority# lead to conclusions con.
Owing to the very slow excretion or
destruction of Atabrine in the body it seems
unnecessary to exceed for intravenous
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injection the dose of 0.1 gram, for an adult.
The margin of safety is probablu not great,
and intravenous injection should be resorted
to only in emergency.

The injections should

be made very slowly and timed to take several
minutes for completion.

The total injected

over a period of twenty four hours should not
exceed 0.3 grams.
nin view of the very slow excretion or
destruction of the drug in the body, it is
reasonable to consider that a course of treatment with it should not be repeated within a
period of say, eight weeks, and that the drug
should be taken under supervision of o physician." (7)
Graphs IX and X (8) shown herewith, show
the therapeutic responses to 0.1, 0.2, and

0.3 gram doses of Atabrine musonat when given
intravenously.

It will be seen that 0.1 gram

is quite an inefficient dosage.

In three

cases, treatment at an effective dosage had
to be given before the end of the customary
seven-day observation period and therefore

l

GRAPH

I

ACUTE SUBTERTIAN MALARIA

I

100
Cl)

....

w

'\

I-

ci5
<(

a:
a..

<(

\

'

\

75

\

\
\

:I:

\

I-

3
w

'

\

50

\
\
\

\

(.?
<(

\

I-

\

z

w
0

a:
w
a..

\
\
\

25

\

',

..........

''

\

............. .... ....

-~-.

:-...

3

2

4

5

7

6

DAY OF TREATMENT.
GRAPH

JI

IACUTE SUBTERTIAN

100

MALARIA

I

a:w
>
w

u.
:c
I§
UJ
(.?

75

50

<(

I-

z

w

0

a:

w 25

CL

0-24

25-48

49-72

73-96

97-1 20 1 21-144 145-1 68

HOURS.

QUININ~ BIHYDROCHLORI DE
u

ATEBRIN
u

M U SONATE

"

2 GMS . PER 10 0
u

CM
AT
u

0. 4

O.'?,

K G. 8 . W. -

u

u

GM , DAILY DOSE
II

u

u

u

-

~no fever endpoint was obtainable so that the
full

seven-day curve could not be completed.
0.2 gram was found to be a fairly ef-

ficient dosage, though in one case, fever and
parasites persisted throughout the seven days.
0.3 gram was still more efficient, a
striking feature being the rapid fall in temperature--in eight out of the ten cases the
fever had disappeared within twenty four hours.
"Notwithstanding the ready response to
intravenous treatment at efficient dosage,
we are in full agreement with the makers that
the route of choice is intramuscular.

In-

tramuscular injections produce a rapid effect
on trophozoites and fever, and the appearance
of Atabrine in the urine within ten minutes
of injection indicates a sufficiently rapid
absorption into the general circulation." (8)
Graphs I and II it will be observed
that, so far as the disappearance of parasites and of fever can be regarded as criteria
of therapeutic activity, Atabrine musonat
was slightly more rapid in its effect than
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I

~quinine bihydrochloride.
Graphs III and IV (8) it will be seen
that no significant difference in the schizonticidal effects of the two drugs was evident in these heavy infections, though Atabine musonat was distinctly more ravid than
that of quinine bihydrochloride.
Graphs VII and VIII (8) from these
graphs it is clear that Atabrine musonat,
though ii efficiently disposes of the sexual
forms of the benign tertian malarial parasite,
is not an efficient subtertian gametocide.
Nor does it affect the viability of the gametocytes, for five out of six crescent carriers on whom mosquitoes were fed at varying
times from the fourth to the tenth day were
found to be infective.
Thus, the important conclusions to be
drawn from the above piece of work are as
follows:
1. The optimum daily dose is found to be

0.375 gram at Atabrine musonat.

This dose

efficiently controls an acute attack of malaria,

g§_.
given on two successive days either intramuscularly or intravenously.
2.

Five hundred samples of urine from

both groups were tested for urobilin; the
findings do not suggest that the urobilinuria
associated with Atabrine musonat treatment is
more than that of quinine treated controls.

3.

Three cases of severe nervous dis-

turbance following Atabrine musonat are recorded.

4.

Although Atabrine musonat efficiently

controls an acute attac~ of malaria, its
routine administration is not advisable.
Oral therapy is the method of c hoice in the
majority of oases and the alarming nervous
sequelae occasionally oocuring after Atabrine
musonat injections are a serious objection to
its general use.
A brief summary of 21 cases in which
the authors were dealing with unusally heavy
infections in a poor and mostly underfed .
class of patients, showed us a few more
points of interest. (9)

They found that

ll,_.

crescents (gametooytes) were in no way influenced, and that these must be destroyed
by plasmochin.

In some oases there was a re-

appearance of parasites in the blood after a
few days, but they disappeared spontaneously;
and in no case observed was there any return
of fever after two injections.
Prophylactic use of Atabrine has been
worked with to quite some extent and one
group of men (10) found that their observations confirmed the results obtained by other
observers who had given prophylactic treatment
for at least 10 days after exposure to infection; namely that Atabrine gives more constant protection than quinine, and that the
prophylactic action of the drug on P. falciparum infection seems to be more constant
than on P. vivax infection.
"The prevention of infection by a prophylactic treatment of 11 days, compared with
our previous results obtained by a prolonged
treatment during the incubation of malignant
tertian malaria and the negative results of

g§_.

other observers who did not go beyond an 8
day oourse of prophylaxis, is an indication-it seems to us--that the therapeutio aotion
is upon the sohizogonio forms of the parasite

and not upon the sporozoites or any intermediate stages.

We mention in support of

this hypothesis our observations on the laok
of infeotivity of the blood during the first
5 days of the incubation period of malignant

tertian malaria." (10)
0 t he rs ( 11 ) s a y t ha t in t he pa s t , t re a t ment of oarriers and prophylaxis with quinine
has been found to be unsuooessful.

Investi-

gations oarried out upon the CCC enrollees
have shown conclusively that the use of Atabrine
as a prophylactic agent is successful sofar

as infection with P. vivax is oonoerned, but
that it should not pe ooncl~ded that Atabrine
is put forward as a drug which would eliminate

malarial infeotion as water does fire.

"Af-

ter administering Atabrine to some thousands
of patients, £t has been found that untoward
actions are almost never encountered and when

~encountered are of a transient character.
II

n

To be fair about any presentation a.nd
also that we, o,s physicians, shall not be

taken by surprise at the occurence of untoward effects, though they be Jew and far between, we shall treat to some extent (but
completely) the evidences found by reputable
researchers and contrary to the very exuberant aooeptanoe of Atabrine as "the new-

! ound

s av i or

".
First, let us remind ourselves that

Atabrine, according to the predominenoe of
opinion, is non-gametocidal; and bring proof
from the work of Sinton. (12) He reports
from his work that Atabrine is known to produce morphological changes in both the sexual and asexual forms of P. vivax and P.
malariae, and also in asexual forms of P.
Jalciparum.

On the other hand, it is re-

ported by many workers to have no action
upon the gametooytes of the last parasite.
When the drug is given to a patient showing
mature crescents in the peripheral blood,

.1Q..

these forms are apparently unchanged and are
still capabl~ of causing transmissal infection in mosquitoes.

His conclusion is that

although Atabrine brings about morphological
changes such as clumping of the pigment and
even the absence due to the extrusion of this
substance in gametocytes, they still seem to
be perfectly capable of undergoing their
development in the insect host.
The untoward effects of Atabrine appear
to include:

gasping or accelerated respir-

ation, circulatory failure, collapse, vomiting, possibly rise of temperature, psychoses,
loss of appetite and of weight, abdominal

pain, headache, diarrhea, yellowed sclera,
rather persistent yellowing of the skin; and
in view of the very slow excretion or destruction of the drug in the .body, it is reasonable
to consider that a course of treatment with
it should not be repeated within a period of
say, eight weeks, and that the drug should be
taken under supervision of a physician only.
Overbeek (13) announces that in view of

11.,.

a series of cases half o which were treated
with quinine and the other half of which were
treated with Atabrine 1 34% of the quinine group
harbored parasites after three weeks as compared to a low 5.6% from the Atabrine group.
He did

1

however

1

bring out a point that we

have seen before 1 namely and Atabrine-treated
case followed by acute mental disorder which
lasted fourteen days.

A month later the pa-

tient had a second attack of malaria; anxiety
and mental confusi on followed the administration
of 0.3 gram of Atabrine. The treatment was
continued for three days but fever and parasites persisted. The administration of 1 gram
of quinine reduced the temperature to normal
and the patient became quieter.
Animal experimentation results have been
culled from this presentation as nearly as
possible 1 but one bit of work done by a group
at the Albany Medical College warrants at
least brief consideration even though its results have not been as yet upheld very strongly in clinical observations; for it is to be

,lg,.

remembered that we have very few 1 if a,n,y observat tons fro m the human neoropsy table as
yet.
An experiment oarried on in dogs in the
department of pharmaoology of Albany Medical
College showed the following to be true of
Atabrine medication:

l.

33 or 66% of the

acute minimum lethal dose daily for fourteen
and four days respectively resulted in an
impairment of hepatic functi on as measured
by the bro-msulphaletn and btl irubin tests.
2 • In con t r a s t da i 1 y med i, cat i o n wi t h 1 7% of
the minimum lethal dose for six weeks revealed no significant reduction in liver
I

function.

3.

Chronic doses of Atabrine

ranging from 17 to 66% of minimum lethal dose
administered daily for a period of 42 days
gave no evidence of renal dama ge.
PLASM OCH IN

•

After seeing that the ef f ects of Atabrine
are nearly wholly schizogonic our next question is 1 "Can we make our the r apy more effeotive1 more prophy l actic and generally more

,,
*
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ll•
_complete by adding to Atabrine therapy a drug
which has gametocidal powers?

If so, are the

two drugs compatible and under what conditions
are they oompatible7"
Plasmoohin, aooording to the surveys to
date, is our drug for this purpose and though
the work has not been nearly so extensive as
that on Atabrine, it gives, we believe, substantial experimental and clinical evidence
to warrant its use for further exploration of
its therapeutic value.
A very cautious bit of work was done (14)
using, in one oase a single, small dose oft
cg. (0.005 gm.) of Plasmochin and observing
a definite effect on the viability of crescents as measured by mosquito infection tests.
Degenerative changes in crescents after the
use of plasmoohin did not appear to be definite enough to measure the early effects of
small doses of Plasmochin, but the conclusion
stated that it was probable that the general
use in a population of suoh small doses of
Plasmoohin would be safe and effective in

3li_.

reducing the transmission of malaria.
As w i, t h mo s t o t he r bas i c drug s, t he r e
are several forms and combination to be had
and the same is true for Plasmochin.

"Plas-

~oohin compound", generally means 1/16 gr.
Plasmoohin and 2 grs. quinine and is put up
in tablets to be given two or three times a
day.

"Plasmochtn compound" i,s employed in

malaria of all ~i,nds:

1. For the acute symp-

toms, 2. To rid the blood of gametooytes.
"Pure Plasmoohin" is employed £n tertian
or quarian, not aestivo-autumnal as: 1. A
substitue for quinine in quinine £diocyncraoy,
2.

A tasteless substitute for quinine for

ohil dren.
The

toxicology of this new drug is mani-

fest in nausea# vomiting, epigasiric pain,
splenic and liver tenderness, oyanosis, methemoglobinuria, mehemoglobinemia, hypo-glyoemia, pallor, headache, dizziness
imur ta, and pro st rat ion.

1

hemoglob-

Bad effeots

1

though

usually mild, leave it suited for use under
supervision only and not appl i cable for prolonged treatment or prophylax i s.

It is used

,li.

with great caution on patients with kidney.
liver or heart disease or marked anemia for
severe symptoms may develop suddenly and without previous warning.
Imperial Chemical Industries Limited have
synt~esized a substance--Pamaquin--which they
believe is chemically identical with Plasmoquine (Bayer).

As Plasmochin is not a crys-

talline substance, and as there are no chemical
tests by which certain isomers can be distinguished from Plasmochin 1 it was considered
necessary, before placing Pamaquin on the
market, to subject the substance to critical
examination, in order to .ascertain whether

£ts biological effects were identical with
those of Plasmochin.
Pamaquin tablets (Pamaquin methylene
d£-(2:3 hydroxynaphthoic acid)) were given to
four adult men. (15) One of these was a normal,
healthy individual, another was naturally infected with P. falciparum, and the other two
were naturally infected with P. malariae.
Each was given 3 tablets daily for 5 consecutive

.iQ..

days; one tablet oontaining the equivalent
of 10 mgm. of Pamaquin dihydroohloride.
l

The

conclusion was that the biological action of
Pamaquin (I.C.I.) had been compared with that
of Plasmoquine (Bayer) and that the toxicity
of the two preparations was the same, as was
also their activity in canary, fowl, mon~ey
and human malaria.
A brevified presentation of a series of
opinions is boring to say the least but in
this case it is the only way that we can find
to present the evidence that we feel necessary
to a complete-to-the-present ~nowledge of
Plasmochin and some of its related compounds.
Strickland and Roy (1932a) bro~e all
surprise records by noting that Atabrine administered to a patient suffering from malaria
completely prevented the development in the
mosquito of any gametooyte from that host,
and that the parasite resumed its developmental powers three days after the discontinuance of the treatment.

In the same year,

the above authors (1932b) rectified their

.li,.

statement by saying " ••• We have reoently tried
without suooess to repeat our experienoe regarding the influenoe of Atabrine on the
development of malarial plasmodia in the mosquito,

reported in the April number {of the

Ind. Med. Gaz~) of this year."
Simonin (1928) observed that the gametooytes oontinued their development £n the
mosquito unoheoked, with the use of various

drugs other than Plasmoohin, and concluded
that there was no drug which affects both the
crescents and ring forms of P. flaoiparum.
Barber and Komp (1927) showed that the
gametooytes of malignant tertian and benign
tertian would not develop £n the mosquitoes
fed on persons after two days' continued
treatment with Plasmooh£n and quinine, and
pointed out the importance of this finding

in the possible control of malaria by treatment.

In the authors' own language, "should

it prove that small doses of Plasmochin may
so cripple gametooytes or so far interfere

with their normal development as the case may

be# that they are rendered incapable of forming healthy oooysts# the usefulness of Plasmoohin combined with quinine# could be greatly
extended."
The accompanying table shows the results
of comparable work done by Chopra and Basu.(16)
Chemistry and Preparations. The synthesis of quinoline compounds of this
type was suggested by the fact that methylene blue is somewhat plasmodicidal,
and the introduction of aminoalkyl groups was found to enhance this propert_y.
Plasmochin is a quinoline derivative, 6 methoxy-8- (a-methyl-8-diethylaminobutyl)
aminoquinoline, and has the following structural formula :
CHaO /

I

Plasmochin
. The drug is a tasteless white powder available as the hydrochloride salt in
pills or capsules. It is also dispensed in tablets in combination with quinine sulfate
in fixed doses.

SULFONAMIDES

The great enthusia.sm shown for the sulfonamides on their arrival on the medical
horizon was as prevalent in the field of
Tropical Medicine as it was elsewhere# but
the common concensus of opinion now is that
this enthusiasm was a short-lived affair .

.12..
On the whole. we found this to be true. but
there are some very definite reports voicing
opinions too reasonable and too well founded
to be ignored; it is not yet to be said that
the sulfonamides are a closed· issue in the
treatment of malaria.
On reporting the efficacy of Promin.
Coggeshall & Best (17) said that in a series
of seventeen patients acutely ill with vivax
and falciparum infections treated with sodium
p, p 1 -diaminodiphenylsulfone N. N'-didextrose
sulfonate (Promin).

results revealed a def-

inite effect on naturally acquired human malarial infections.

The vivax infections were

more resistant to therapy than the falciparum
and the infections in the native Negro residents were more responsive to the drug than
the same infections in the relatively nonimmune white patients.
Thirteen patients with vivax, falciparum
and quartan malaria were treated with 2-sulfanilamido pyrimidine (sulfadiazine).

There

was a demonstrable effect in 10 oases but none

!tQ..
in 3.

Although the effeot of this drug was

definite, it appea.red to be 1 ess aotive _ than
promin when given under the conditions desori.bed.
"Fr om t he o b s e r v a t i, on s o i t e d,

i, t

s e ems

apparent that there is ample evidenoe to
show that these new types of oompounds, unrelated to quinine or Atabrine, possess oonsiderable aotivity against experimental and
human malaria and, with related oompounds,
just i, f y further study. "

( 1 7)

These reports were enthusiastic enough
but in the observer's own words: "It should
be emphasized that at present there are no
reasons for giving the drugs i n preferenoe
to quinine or At~brine for the treatment of
malaria, and they should be reg a rded only
as important substitutes."

Sulfathiazole (18) was used to terminate
artificially induced malaria in nine patients;
relapses ooourred in five of this group and
the antimalarial aotion of sulfathiazole was
slower than that observed with quinine.

YJ_.
Prontosll, when reported (19) in ordinary
therapeutic doses (3 to 4 gm. daily for five
days) had an undoubted action in causing disappearance of malarial parasites from the
peripheral blood and in controlling symptoms
of the disease.

It destroyed both ~sexual

and sexual forms of P. vivax and P. malarlae
and only the asexual forms of P. falciparum,
but had no action _on the crescents.

Its

action on P. malariae appeared to be comparatively slower and less potent than that
on P. vivax.
In smaller doses (1.5 to 2.0 gm. dally
for five days) the symptoms of the disease
abated and the parasites disappeared from
the peripheral blood but . recrudescence of
the disease occurred within a fortnight.
Prontosll undoubtedly possesses mild anti- _
malarial properties in infections with Indian
strains of malaria and may be worthy of
trial when other antimalarial drugs are not
available or are contraindicated.
Another report on the value of Prontosil,

!t_g_.
given by Niven (20) affords the following
quotation:

"The present investigation has

shown that Proniosil has some lethal aotion
on malaria parasites, a fact that is of
qoedemic interest in view of the relatively
simple structure of the drug.

Somewhat sur-

prisingly it appears to be more effective
against P. faloiparum than against P. vivax.
As a practical addition to the therapy of
malaria, however, the drug has no place.

It

£s obviously muoh less than quinine, is more
dangerous, and is much more oostly."
UNDERLINING IS OUR OWN)

(THE

A translation of a report by Dr. Amonario
Diaz de Leon and thought to be the first report
on the use of sulfonamide compounds in the
treatment of malaria, brought out the following favoring facts.
First oase: P. vivax demonstrated, underwent three fever attaoks before given the
medicine, five days later returned for oonsultation feeling perfeoily well and having
suffered no attacks during that period.

u.
Second and third oases:

Two brothers

suffering an attack of fever on the same day
(P. vivax demonstrated in each case) and
both patients suffered only the initial attack# before treatment.

Seven days after

the first consultation no parasites could be
found in the blood.
Fourth oase: A woman who had had an
abortion followed by general malaise# lack
of appetite and headache. Soon came chills#
fever and copious sweat. Benign tertian
parasites demonstrated. Last attack appeared
the day after the initial dose and was light
with only a slight ohill and temperature
rising only to 38 degrees C. disappearing in
three hours# in contrast to the former attacks which had lasted eight to ten hours.
"After having treated fifteen cases of benign

tertian fever with complete success, I am
sure that rubiazol is an effective# specific
drug for this form of malaria ••• " ( RUBIAZOL

IS THE SAME AS PRONTOSIL AND PRONTYLIN)
Sulfapyridine (2 sulfanilylamino pyridine)

!El_.
was used in experimentati on on monkeys and
some encour~ging results reported but the
work was so brief that the only conclusion
was that the drug was worthy of trial £n
human oases. (21)
One of the most encouraging reports on
this group was one on the use of Soluseptas£ne, (22) a white crystaline powder of
well refined chemical constitution. It is
readily soluble in water to give a solution
of approximately neutral reaction. Concentration selected by the manufGcturer for
clinical use is 5i. A solution of this
strength is very nearly isotonic with the
blood and is, according to the manufacturers,
well tolerated by subcutaneous, intra-muscular or intravenous injection by all common laboratory animals and also by man.

It

is said to be much less toxto in the exper-

imental animals than the other sulphonamide
derivatives and no serious, untowards effects
have been reported following the use of
soluseptasine.

!t.2•
One of the monkeys suffer i ng from a lowgrade infection with P. knowlesi was injeoted
with 2 ocm. of soluseptasine , i.v. It had been
showing a fair number of parasites {both
schizonts and gametooytes) in the blood but
24 hours after the injection n o parasites oould

be dem onstrated even in thick blood films.
To waiver the question of spontaneous disappearance of the parasites as is common with
monkeys with a ohronio infection, a fresh monkey was innooulaied with 3 ocm. of monkey blood
showing an infection with P. kno wles£.

On the

14th day after innoculation a few parasites
appeared in the blood films and when the parasite count was very high the monkey developed
hemoglobinuria and looked very ill. At this
stage, 2 ocm. of soluseptasine were injected,
i.v.; next day the animal looked better and
there was not only a considerable fall in the
parasite count bu there were also definite
degenerative changes in the parasites.

The

same dose was repeated 24 hours later, i.m.,
and after the two injecti ons no parasites

could be found.
COMBINATIONS
�Ii seems reasonably evident with the
information that we have up to the preseni.
ihai no one drug is completely adequaie io
do the complete job all by itself. A1abr£ne
worked on the schizonts. the Sulfas seem to
be effective £n much the same way and Plasmo
chin is the only one that has a dependable and
marked effect on the gametooytes which are
ihe beginning of the sexual cycle and are also
just what the mosquito's probosous is hunt
ing as he drills it though the outer layer of
a malaria patient or carrier.
Now to the question. are combinations of
schizoniicides and gametocides compatible
and effective as they would seem to be theo
reiically1
Nai£lla. Fabrega and Vich (23) prescribe
for persons over 10 years. Atabrine 0.3 gm.
doily for seven days. a pause of three days.
then Plasmochin 0.03 gm. daily for 5 days.
They claim. from 100 cases. rapid oure ond

!ll_.
protection from relapses in benign and malignant tertian malaria.

This treatment is not

contraindicated in pregnancy, and Atabrine
is the drug of choice in blackwater fever,
J:u,lowed by Plasmochin if gameiocytes are
present.
During the years of 1933 and 1934,
another bit of work was done using Atabrine
as a schizonticide, and Plasmoohin as a

gametoc£de. (24) Throughout two malarial
seasons there was satisfactory control of
gametocyte productions, believed due to
Plasmochin.

Atabrine was found to be par-

ticularly effeotive in the sterilization of
carriers and in the short course of treatment
necessary, the effectiveness of Atabrine as

a sohizontioide and the efficacy of Plasmochin
as a gametooyde were proved to the satisfac-

tion of the author.
Results (25) of treatment with Atabrine,
Plasmochin and quinine, singly and in combination, in 1,696 cases in a group of military personel, using the recurrence rate in

!:f§_.

those oases observed for six months or more
following an attack as the sole criterion of the
success or failure of a treatment. The following conclusions were drawn:
1. Atabrine alone, has failed to prevent
recurrences to a greater extent than any other
iype of treatment.
2. Quinine, in the 1 arge and cont i,n,ued
doses given here, has somewhat greater relapse

preventing properties than has Atabrine in
vivax malaria and markedly greater ones in
falciparum malaria.

3.

Plasmoch,in, in the daily doses com-

monly used, given concurrently with or foilowin,g Atabrine, has a very definite and pronounced effect upon the relapse rate in all
types of malaria. This effect is especially
noticable in the vivax oases in this series.
Thts finding is in absolute agreement with
the recent conolu~ions of the Ma+aria Commission of the League of Nations Health Or- _
ganization.
Another extensive experimentation was

~done on a patient infeoted with P. falciparum
giving Atabrine 0.1 gm. (t.i.d.) for the first
five days at the end of which time the ring
forms (sohizonts) had completely vanished but
the crescent forms (gametooytes) had remained
absolutely unchanged. For the second five
days Plasmochin was given .02 gm. (b.£.d.)
with the result that the orescents vanished from
the blood on the fifth day and had shown diminution in number on the fourth day. (26)
Drugs may be tried for three purposes:
preventing infection from developing in the
human; preventing development of sporozoites
in the mosquito; or sterilizing the parasites
in the human carrier.
Prophylactically speaking, quinine controls the clinical attacks but does not prevent infection of the patient; Plasmochin
definitely hits the gametocytes of P. faloiparum and has been credited for prevention of
the sporogenous cycle in the mosquito; and
Atabrine (prophylactically) is in question to
its power to control the infection of the

2-Q..

pati,en,t, but it definitely does prolong th,e
i,n,cubati,on,.
A n,ew,

sci,en,ti,fi,c system has been, recom-

mended (27) for preventi,on, of relapses an,d
here ts the idea with n,o attempt made to give
treatment for the prevention of relapses duri,n,g the primary attack.

One waits until the

first recrudescence and then, one uses the
speci,fi,c remedtes in such a way that they
wi, 11 as s i s t , r a t he r t ha n hi nd e r, t he de v e 1 opmen, t of the pat£ent's natural defensive
forces ••• by repeating this plan, with the same
watchfulness during the second recrudescence
(using the specific drug at a later period
and more spari,ngly than, i,n, the first recrudescence) and again,, i,f necessary, during a
thtrd recrudescence, it happens in most oases
that the patient becomes fortifi,ed or premun,ized against the disease to the extent
that he not only ceases to suffer relapses,
but fails to have an attack when he is reinfected.
In order that we may avoid repetition let

li•
it be said that out of 192 cases treated with
Atabrine and Plasmochin in dosages the same
as we have encountered in most of the previous
reading# the results were reported good# there
was no drug intolerance and no relapses.

The

same workers# (28) using these drugs prophylactically found only 3 cases of malaria out
of 242 persons treated as compared with 126
cases out of a series of 854 persons tried
prophylactically on quinine.
Before dropping the subject of using
combinations of sohizontocides and gametocides
it would be well to add our words of warning
as we have gathered them during the course of

this compilation,.

It is inadvisable, in an

attack of malaria, to use mixtures of different
sohizontocides, or mixtures of schizontocides
and gametocides.

A mixture of Atabrine plus

Plasmochin should be particularly avoided.
These two substances, if administered simultaneously, produce a high percentage of toxic
disturbances.
It appears to be clearly superfluous t

5.£.
administer a daily sub-toxic dose of Plasmoohin in order to devitalise the gametocytes.
A single dose of 0~02 gm. repeated if necessary, every five days (but only £n the rare
oases in which the gametocytes still persist), will have the same effect. The admin£stration of this sub-toxic dose of Plasmochin
during five days, notwithstanding certain
cyanotic disturbances, may be continued without further incident.
MISCELLANEOUS DRUGS
Certuna (Ci1£onal) is a new drug with a
gametocytoc£dal action resembling that of
Plasmoch£n, and has been reported by K£kuth
(1938) from the Eberfeld Laboratories of
Messrs. Bayer. (29)
The drug was well tolerated in every
instance and even when large doses were given
did not produce any unpleasant or abnormal
manifestations but the proof of the experiment £sonly against oertuna when used with
the Rumanian strain of P. falciparum.

The

conclusion was that oertuna, even in doses

5J_.

as great as 0.06 gram t.i.d. for

7 days com-

mencing the day before infection, produces
no true prophylactic action against the dosage of sporozoites of the Rumanian strain of
P. falciparum.
Another group found that a total dosage
of 0.35 io 0.4 gram of cilional administered
as a dose of 0.03 gram three times a day,

is

usually sufficient to eradicate practically
all gametocytes of P. falciparum from the
blood and even this high dose has been borne
by the patients experimented upon, without any
ill effects. (30) In the author's own words:
"On considering the points discuesed above we
cannot, however, help arriving at ihe conclusion that Plasmochin is preferable to cilional,
inasmuch as a much smaller dose of the former
effects the eradication of crescents in a
comparatively short time, and as the dosage
of Plasmochin (as advocated by Knowled and
Das Gupta) is not at all toxio and perhaps
cheaper than its rival."
The sharp limitation of the field of

5.E_.
effective action to the gametocyies of P.
falciparum implies that certuna is inferior
in its plasmoo£dal range to Plasmoch£n and
cannot replace Plasmochin
tocide.

as

a general game-

Combined w£th a schizontocide, the

drug might ee of value in the treatment of
sub-tertian malaria were it less toxic than
Plasmochi,n, and yet equally effective.

Whether

the drug is entirely harmless or not is uncertain.

The use of certuna in effective pro-

phylaxis would necessitate more accurate
species diagnosis than is usually possible in
the field of practice.
C1 a r 'k,

( 31

) rep o r t s t ha t C£1 ion, a 1 ,

be -

longing to the Plasmochtn series of preparations, shows quite a potent action on the
gametes of P. falciparum in doses far less
than that which would produce toxic symptoms
and is considered by him to be superior to
Plasmochin as a gametocide in malignant
tertian malaria.
"Malar£an" or variance of this name,
I

seems to be a popular term for proprietary

.2.5...
malarial remedies.

"Malarian" is described

as a nonpoisonous vegetable drug, which is

cheaper than quinine and free from the unpleasantness associated with quinine treatment, and which has been used "with a large
measure of success" by an · English investiga-

Its action in acute malaria was untried,

tor.

and a request was made that the drug be put
to a suitable test.

Such was done (32) and

though the number of oases treated was small,

it was sufficient to indicate that this preparation is so Jar inferior
to quinine bi,
hydrochloride as to have no place in the
treatment of acute malaria.
"Malario", a new preparation received
from a Singapore firm was claimed to give
satisfactory results in the treatment of
malaria (types not speoified)--rapid relief
of symptoms with no recurrences over a period
of months.

The preparation was in the form

of a brown powder with a slight chocolate
taste.

S.S. Government analysist reported,

that it contained two parts of arsenic per
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million and no trace of any other deleterious
substance and did not contain Atabrine or
quinine.

Tests made on 47 oases (32) of acute

malaria with the following conclusions:

"Ma-

lario is of no value in the treatment of acute
t

P. falciparum malaria and a very low efficiency in acute P. vivax malaria."
Sulfonamide conclusions dra,wn from the
same reports are the same as those that we
have stated before and the general conclusion
was that they have no place in the practical
treatment of malaria from its low efficiency
and high cost.
In an attempt to facilitate administration to young children the manufacturers
have prepared a new compound, allied to Atabrine and called "A. Granulate".

It is

made in the form of yellow granules with a
slightly sweetish taste and has not appeared
on the market, as yet.

Work done with a small

quantity sent to the Institue indicate that
the drug is inferior to Atabrine for the
treatment of acute malaria. (32)

5.1..
Malaria has always been a serious problem
in the southern part of China.

The root-bark

of an indigenous tree under the native name
of Pai-ohi 1 ang-kan or Ken-yen-yao has been
used by the southern Yunnanese for the last
thirty years as a remedy for the relief of
intermittent fever and also as a mild laxative.
Concerning its medical application, no literature in any form is obtainable. For the sake
of convenience we shall denote it as the sin, i

ne tree.

"In the summer of 1939 we tried the powder of the root-bark on 34 malaria patients
of Hsiao-ku-lang District, Kunming.
them were children.

Most of

On the average, they

came to our institute about eleven days after
the onset of symptoms.

We treated them with

3 grams of dried powder t.i.d. after meals
for adults, and corrected doses according to
Young's rule t . i.d. for children.

Within

eight days, parasites disappeared from the
blood smears from acute subtertian, acute
'

and chronic tertian or quartan oases.

For

~.
chronic subtertian cases it seems to be less
effective.

After several days the enlarged

spleen became much smaller. Equivalent doses
of fluid-extract of the root-bark were just
as effective. At the beginning of this year,
we again examined the blood of the treated
patients. All blood smears were ,negative,
indicating that there was no recurrence.
Stem, bark and leaves are also effective.
With children, however, sinism was produced by large doses, either double or even

40% over the normal amount.

Some developed

either vomiting or tinnitus aurium.

The

latter symptom in one oase lasted nearly
three weeks after cessation of treatment.
Only one case developed slight diarrhea with
the powder of the root-bark; thus its laxative action was not marked.
In conclusion, this drug may be said
to be more potent than, and just as satisfactory as, quinine for the treatment of
all kinds of malaria.

It takes on the aver-

age, four days to kill malarial parasites
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in the blood.

Its pharmacological actions,

side effect and toxicological properties are
very similar to those of quinine.

Since

this species is very widely distributed and
oan be grown everywhere very easily, on the
limestone mountains in the southern part of
Yunnan province and even in Kunming through
the long, windy dry weather, its economical
value is undoubtedly much greater than that
of quinine."

(33)

Another drug which for the sake of convenience may be termed the ohunine tree contains an active alkaloid chunine, with even
greater antipyretic and infusoriacidal actions,
very much like quinine and sinine.
Benign tertian malaria in a patient with
acquired anaphylaotoid reaction to quinine
was successfully treated with quinidine, the
dextrorotatory isomer of quinine, without
discomfort to the patient.

A positive skin

test was obtained to quinine but not to its
dextrorotatory isomer, quinidine.

A son

appeared to have inherited a form of quinine

Q.Q..
intoleranoe, as he suffered from urticaria
on the one oooasion when it was given, but
he gave a negative skin test to quinidine.
Quinidine sulphate, U.S.P., given in
10 grain doses once a day about two to four
hours before the ordinary hour of the paroxysm, has given prompt and good results in a
small series of patients with malaria. (34)
The results strengthen the suggestion of
Dawson and Garbade that quinidine may well
be given a trial in the treatment of malaria
in cases of quinine intolerance.
All four oommon cinchona alkaloids are
of approximately equal value in ohronio
benign tertian malaria.

In oases of quinine

idiosynorasy, taking the form of · urtioaria,
coryza or dyspneic attacks, quinidine or
oinchonine may be given a trial with fair
prospects of avoiding the unpleasant side
effects, and especially in the case of quinidine, security as to therapeutic efficacy of
the treatment.
Preliminary observations (35) indicate

fil_.

that hydrocinohonidine and hydrocinohonine as
we11 as hydroquin£ne and hydroqu£nid£ne possess definite antimalarial activity, a result

of some theoretical importance.
An experiment testing the use of calciu~
chloride as treatment for the chills occuring
in malaria reveal the following: (36) 1. Three
patients suffering from malaria (induced in
the treatment of neuro-syphilis) were available for study.

In this group calcium chlo-

ride was administered on five ocoasions.
Immediate relief from the chill was obtained
in all five instances, but in two instances
the injection caused nausea and had to be
discontinued, after which the chill recurred.
The preparation of calcium chloride used was
a 10% aqueous solution.

The usual quantity

injected was 10 co. although as muoh as 20 cc.
has been given.

The solution should be in-

jected very slowly as it has been found that
if given too rapidly the chill manifestations,
although initially relieved may recur.
Very briefly, let us present some newer

62.
and less important forms of treatment: (37)
1. Antimony tartrate--after small doses
the patient oannot infeot mosquitoes.
2. Dr. J. Lavergne stated that synthetic
drugs (quinaorine for five days followed by
rhodoquine for three days) gave better results
than quinine.

3. Tibours~aja reports from Mosoow the
use of quinoline as a gametooide--eliminated
subsequent infectio~ of mosquitoes that were
fed on the patient 24 hours after the last
dose was given.

4. Mass prophylaxis in a malarial region
of Tunis using premaline in tablet form.

A

table of this drug contains quinacrine 0.01
gram, rhodoquine 0.005 gram, and praequine
0.005 gram.

Symptoms of intolerance were

rare and cost was only half the cost of that
of what daily quinine administration would
have been.

The authors were enthusiastic

about the results.

SUMMARY
In conclusion, it seems that all evidence

points to the use of both Atabrine and Plas
mocnin.

As to the time of administration of

each, perhaps the safer course is the better
so we should recommend not a mixture of the

two drugs (several reports of severe toxic
manifestations) but a five day course of

Atabrine (0.1 gm. t.i.d.) followed by a
second five day course, this time using

Plasmochin (.02 gm. b.£.d.).
If Atabrine is not available, it may be
well to remember ine sulfas and some of the
other fairly effective schizontioiaes, but
the only effective gametocide is Plasmochin.
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